|
BRPI1008364A2
|
|
method to assess risk in multiple sclerosis
|
|
WO2009069008A2
|
|
Composition and method for diagnosing fungal disease
|
|
CA2660820A1
|
|
Method of diagnosing and stratifying anti-phospholipid syndrome
|
|
US2006172338A1
|
|
Method for diagnosing multiple sclerosis
|
|
EP1692519A2
|
|
Method for diagnosing diseases based on levels of anti-glycan antibodies
|
|
US7592150B2
|
|
Method for diagnosing diseases based on levels of anti-glycan antibodies
|
|
NZ585114A
|
|
Elevated serum levels of auto antibodies to IgG, IgA and IgM that bind to glycan structures used in a diagnostic test for MS
|
|
AU2002238821A1
|
|
System and method for creating a series of three dimensional glycan structures databases and their applications
|
|
US6994966B2
|
|
Combinatorial complex carbohydrate libraries and methods for the manufacture and uses thereof
|
|
IL152683D0
|
|
System and method for carbohydrate sequence presentation, comparison and analysis
|
|
US2001051349A1
|
|
Combinatorial complex carbohydrate libraries and methods for the manufacture and uses thereof
|
|
EP1785726A1
|
|
Combinatioral complex carbohydrate libraries and methods for the manufacture and uses thereof
|
